The first survey, which was conducted by CM Research, found that male veterinary surgeons get paid more across all levels and roles
Based on 2016-17 salary data collected from 810 vets across the UK, the survey showed that while the average female partner earns £51,315, her male equivalent earns a pre-tax equivalent salary of £69,755 - a difference of £18,440 (36% more).
The survey also found that female full time vets earn an average £41,152 per year while their male colleagues earn £46,921 - a difference of almost £6,000 or 12%.
On average, female part time vets were found to be earning £1,707 less than their male equivalents - around 6%.
Female veterinary nurses also earn less than their male peers, with average salaries of £19,594 being almost £3,000 less than male nurses - a 13% difference.
The second survey was conducted by The Society of Practising Veterinary Surgeons (SPVS). It looked at data from 700 vets and 630 veterinary nurses in the UK and found a 19% difference between male and female veterinary surgeons' annual salaries, with men earning a median salary of £50,750 compared with women at £40,960.
When analysed by hourly rates (but not accounting for period qualified) rates for women were 18.6% lower (male vets had a median hourly rate of pay of £27.90, compared with £22.72 for females).
When salaries were examined by period qualified, a more complex picture emerged. While male full-time salaries are consistently higher, the differences are more pronounced at senior level.
For example, among vets qualified for up to 10 years hourly rates are broadly comparable. But there is a significant difference among vets qualified for 11 years or more, when the median hourly rate for female vets is £28.22 compared with £35.27 for male vets - a 20% difference.
Peter Brown, SPVS president elect said: "The picture would seem to reflect that seen in other professions where women start out on an equal footing with men, but fall behind as they get older. Unless we address those broader issues which militate against women’s career advancement, there is a risk that significant differences will persist."
Adele Waters, Editor of Vet Record said: "These findings clearly show that inequality is a reality for many women working in the veterinary profession day in and day out.
"If male vets get paid more, it follows that they are valued more highly, but why? There is no evidence to justify such a pay differential and there is a legal reason to remove it. The Equality Act 2010 says men and women in the same employment must receive equal pay for equal work."
"There is growing scrutiny on the gender pay divide across all employment sectors in the UK - and rightly so. Vet businesses must act now to resolve these unfair pay differentials so that future generations of veterinary professionals do not face discrimination."
The BVA says the results echo findings from its own surveys. Senior vice president, Gudrun Ravetz described it as "a cause for concern", urging more openness and transparency around pay and calling for "a system based on objective criteria, to ensure equal pay for equal value."
Coincidentally, Gudrun's comments come only four days after VetSurgeon Jobs and VetNurse Jobs announced a new move designed to bring greater transparency concerning salaries: allowing and encouraging veterinary employers to display the salary and benefits they offer as an integral part of their recruitment advertisements.
Photo: Portrait Of Male And Female Vets In Surgery. Shutterstock / Monkey Business Images.
CM Research, the veterinary market research company, has released the results of a survey which suggests that staffing and HR issues are becoming an increasing challenge for the profession.
629 veterinary surgeons picked from 12 answers to the following question: "What would you say are the biggest challenges facing your vet practice at the moment?"
The biggest challenge, voted for by 42% of respondents, was 'Clients unable to pay their bills'. However, only marginally behind in second place (up significantly from fifth place the previous year), was 'Managing and retaining staff' (41%).
The full results were:
Coincidentally, VetSurgeon.org also carried out some research recently which explored what candidates look for in an ideal job - one of the keys to staff retention and good employer / employee relationships. You can download the report here.
When vets were asked to predict what they thought the future held for the profession, key themes included more corporatisation, more specialisation and the Internet having a still greater impact on business, both in terms of competition and clients consulting Dr Google:
CM Research has announced the results of a survey conducted this month in which veterinary surgeons named Osurnia as the best new product of 2015.
290 companion animal veterinary surgeons took part in the survey, which is designed to provide veterinary surgeons with their peers’ unbiased judgement on which new veterinary products, services or devices have made the biggest impact on the industry.
The questions were unprompted to ensure that the respondents were not influenced by pre-set survey options. CM Research points to the fact that many of the products that featured in its rankings were launched before 2015, including 2nd and 3rd placed Apoquel and Bravecto, as evidence of this freedom.
The full list of products named more than once in this year's survey was:
Product
Manufacturer
Number of mentions
% of mentions
Osurnia
Elanco
67
23%
Apoquel
Zoetis
58
20%
Bravecto
MSD
29
10%
Semintra
Boehringer Ingelheim (BI)
13
4%
Amodip
Ceva
10
3%
Nexgard Spectra
Merial
8
Broadline
6
2%
UpCard
Vetoquinol
Zodon
5
Metabolic Diet
Hill's
4
1%
Nexgard
SDMA Test
IDEXX
Comfortis
3
Remend
Bayer
Seresto
Yumove
Lintbells
Bovela
BI
2
Comfortan
Dechra
Hill's y/d diet
Nutraquin
Nutravet
Pexion
Prinovox
Virbac
Pronefra
Thiafeline
Animalcare
Veraflox
Vetigel
Suneris
Cardalis
Veterinary surgeons have named their top new veterinary products of 2012 in a survey carried out by CM Research.
As part of the research, 343 vets working in UK practice were asked what they considered to be the best new product of 2012. Their answers were unprompted, and they were only allowed to mention one product or service. For this reason, some vets voted for products that were launched earlier than 2012. The full results were as follows:
Hill's y/dAn iodine restrictive hyperthyroid management food launched by Hill's Pet Nutrition in May 2012 won with an overwhelming 31% of the votes. www.hillspet.co.uk
Cardalis (CEVA Animal Health)Launched towards the end of 2012, CEVA's combined ACE inhibitor / spirolactone for heart failure in dogs scored a creditable 9.6% of mentions. www.ceva.co.uk
Seresto (Bayer Animal Health)Bayer's 8-month flea and tick collar came third with 6% of the votes. www.seresto.com.
Caninsulin Vetpen from MSDLaunched in July 2012, this new insulin delivery pen for Caninsulin is designed to improving dosing accuracy, consistency and ease of use. The user-friendly pen design is said to improve initial pet owner acceptance and on-going compliance.
Atopica Cat (Novartis Animal Health)Novartis launched Atopica Cat, an oral version of its treatment for chronic allergic dermatitis, at the start of 2012. www.itchfreepet.co.uk
Comfortis (Elanco)Launched in 2011, Comfortis is a novel oral flea adulticide for dogs which kills adult fleas rapidly for a month. www.comfortis.com
Nobivac Myxo RHD (MSD)The first vaccine to combine 12 months protection against both myxomatosis and rabbit haemorrhagic disease within a single inoculation. It is a non-adjuvanted vaccine which, according to MSD, delivers greater simplicity of protocol and enhanced disease protection.
Cimalgex (Vétoquinol)Launched towards the end of 2011, Vetoquinol's 2nd generation Cox-2 inhibitor is said by the company to be very well tolerated, have an excellent efficacy profile and be very easy to use, meaning that Cimalgex allows veterinary patients to benefit from pain relief in situations where clinicians would have been worried about the risks versus the benefits of prescribing a NSAID for pain management.
Activyl (MSD)MSD's novel flea spot-on is the first to work by bioactivation, only becoming an insecticide after being ingested by the flea, thus minimising owner's exposure to insecticides. Said to be effective against the other stages of the flea life cycle, too. www.activyl.co.uk
RevitaCAM (Abbott)RevitaCAM is the first and only veterinary NSAID (meloxicam) with oromucousal delivery. www.revitacam.co.uk.
Metacam for cats (Boehringer Ingelheim)Boehringer extended its Metacam 0.5 mg/ml Oral Suspension for Cats range with the launch of a 30ml bottle size in July. www.metacam.co.uk.
Zuprevo (MSD)MSD's antibiotic to combat bovine respiratory disease (BRD) was launched in the third quarter of 2011. www.zuprevo.com
V-Gel (Docsinnovent)V-gel was the first ever species-specific supraglottic airway device (pictured top right), currently available for cats and rabbits. Billed as the latest ground breaking technology for a safer anaesthesia, easier breathing and avoiding damage to the throat and trachea; a safer alternative to ET tubes. www.docsinnovent.com
Onsior (Novartis Animal Health)The tissue-selective oral and injectable Cox-2 inhibiting NSAID from Novartis was actually launched back in 2009.
Certifect (Merial)Merial's flea and tick spot-on for dogs was launched by Ray Mears in the UK in February 2012. www.certifect.co.uk
Calmex (VetPlus)Somewhat controversial when it made its first appearance in 2011, Calmex is a feed to help dogs and cats that may experience behavioural problems as a result of their environment or situations that may cause anxiety or fear. More info.
Comfortan (Dechra)The first licensed methadone for dogs was launched by Eurovet towards the end of 2011, before it was acquired by Dechra in May 2012. www.dechra.co.uk
Hill's Vet EssentialsHill's vet-exclusive petfood range is designed to meet essential dietary needs at every life stage. More info.
Trocoxil (Pfizer)Trocoxil, Pfizer's NSAID for canine osteoarthritis was remarkable for its once monthly dosage regime, when launched back in 2009.
VerafloxBayer launched its next generation fluoroquinolone antimicrobial for bacterial infections in cats and dogs at the end of 2011
YumoveYumove is a joint support supplement from Lintbells, containing glucosamine and chondroitin. More information.